Field Notes From Inner Space
Global Psychedelic Survey Participants Report Health Benefits, Personal Growth, and Life Transformations
Bibliographic Data
| ID | 17534644 |
|---|---|
| Authors | Jill Robinson (0000-0003-2488-531X, University of Victoria, corresponding author), Noah Wallace (0009-0007-4344-1075, University of Victoria), Esenia Cassidy (The Ohio State University College of Social Work), Stephanie Lake (0000-0002-4095-8016, Semel Institute for Neuroscience and Human Behavior, UCLA), Philippe Lucas (0000-0003-1948-3842, University of Michigan) |
| Year | 2026 |
| Publication date | 2026-04-25 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Contemporary Drug Problems (JOURNAL) |
| Journal identifiers | ISSN: 0091-4509 • E-ISSN: 2163-1808 |
| Publisher | SAGE Publishing (PUBLISHER • US) |
| DOI | 10.1177/00914509261444382 |
| OpenAlex | W7155629785 |
| Language | EN |
| References cited | 115 |
Psychedelics are being used globally in a variety of contexts, from recreational use to controlled clinical trials of therapeutic applications. Much of what is known about psychedelic user experiences comes from quantitative studies, while qualitative research is limited and has received comparatively less attention. Qualitative research, particularly personal narratives, can highlight the nuanced impact users have experienced, which quantitative research may be unable to capture. The present study is an exploratory analysis of qualitative responses from the Global Psychedelic Survey 2023, aimed at addressing the gap between quantitative and qualitative literature in naturalistic psychedelic use. Using inductive thematic analysis, three common themes in participants’ accounts of their psychedelic experiences were identified: perceived therapeutic outcomes, enhanced psychological wellbeing and personal development, and profound shifts in life perspective and meaning. Such narratives bring forth detailed accounts of the impact psychedelic users have experienced, as well as potential risks associated with and experienced by participants. Findings are discussed in the context of harm reduction, public policy, and future inquiry into psychedelic substances for health applications
Context (archaeology) · Exploratory research · Harm · Narrative · Perspective (graphical) · Qualitative property · Qualitative research · Thematic analysis · Diverse academic research themes · Forensic Toxicology and Drug Analysis · Psychedelics and Drug Studies
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Survey study of challenging experiences after ingesting psilocybin mushrooms
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Psychedelics, Mystical Experience, and Therapeutic Efficacy
Human hallucinogen research
Psychotherapy for Military-Related PTSD
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Psychedelic therapy for smoking cessation
Psychedelics and Psychedelic-Assisted Psychotherapy
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder
Psychedelics Promote Structural and Functional Neural Plasticity
Psilocybin with psychological support for treatment-resistant depression
Psychedelics
Psilocybin occasioned mystical-type experiences
Psilocybin-assisted treatment for alcohol dependence
To Get High or to Get Out? Examining the Link between Addictive Behaviors and Escapism
Ketamine-Enhanced Psychotherapy
Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration
A New Adjunct to the Treatment of Alcoholism
Self-Medication for Chronic Pain Using Classic Psychedelics
The Global Psychedelic Survey
Making “bad trips” good
Manifest your desires
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems
The History of MDMA as an Underground Drug in the United States, 1960–1979
Subjective Reports of the Effects of MDMA in a Clinical Setting
Tripping into Treatment
Patient Experiences of Psilocybin-Assisted Psychotherapy
Self-Actualization and the Integration of Psychedelic Experience
Cancer at the Dinner Table
On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1
Use of psilocybin ("mushrooms") among US adults
Indigenous psilocybin mushroom practices
Psychedelic medicine at a crossroads
| Citation velocity | historical |
|---|---|
| Highly cited | No |